SEED Innovations Ltd pleased with progress at Little Green Pharma
LGP reported revenue of A$3.7mln in its latest quarter alongside A$4.9mln in cash receipts.
SEED Innovations Ltd (AIM:SEED, OTC:FFRIF), the medical cannabis investor, said it was encouraged by the progress of ASX-listed Little Green Pharma, which posted record revenues in its latest quarter.
Alfredo Pascual, at SEED, said: “We are pleased to see the recent distribution agreements throughout Europe and Denmark’s first locally produced cannabis medicine registration.
“With a strong cash balance of over A$25mln and a A$5.8mln financing facility from National Australia Bank, SEED are looking forward to a positive 2022 with further progress and news flow from the LGP team.”
LGP reported revenue of A$3.7mln in its latest quarter alongside A$4.9mln in cash receipts.
SEED owns 3.1% of LGP’s issued share capital
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…
In exchange for publishing services rendered by the Company on behalf of SEED Innovations Ltd named herein, including the promotion by the Company of SEED Innovations Ltd in any Content on the Site, the Company…
Read More: SEED Innovations Ltd pleased with progress at Little Green Pharma